2021–22 Departmental Plan: Health Canada
Health Canada will also continue to identify and acquire COVID-19 treatments and therapies; expedite regulatory reviews of drugs, medical devices and disinfectants; procure any needed medical and personal protective equipment; prioritize the review of COVID-19 tests, including new, innovative options and technologies; and pursue strategies to expand testing capacity.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
2021–22 Departmental Plan: Health CanadaHTMLEnglish publication HTML
-
2021–22 Departmental Plan: Health CanadaHTMLFrench publication HTML
Similar records